Back to all news
AI Model Improves Differentiation of Brain Tumor Progression from Radiation Necrosis on MRI
A York University-led study shows a novel AI using advanced MRI can distinguish between progressive brain tumors and radiation necrosis more accurately than human assessment.
Key Details
- 1AI model uses attention-guided deep learning with chemical exchange saturation transfer (CEST) MRI.
- 2Study included over 90 patients with brain metastases treated by stereotactic radiosurgery (SRS).
- 3AI achieved over 85% accuracy in distinguishing tumor progression from necrosis, compared to ~60% for standard MRI and ~70% for advanced MRI alone.
- 4Published December 2025 in International Journal of Radiation Oncology, Biology, Physics.
- 5A crucial clinical challenge as treatment decisions for tumor progression vs necrosis are substantially different.
Why It Matters
Differentiating tumor progression from radiation necrosis on MRI post-therapy is a major clinical challenge, as each requires different treatments. AI that improves diagnosis accuracy could substantially impact patient management and outcomes in neuro-oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.